OTTAWA, June 26, 2017 (GLOBE NEWSWIRE) — ABcann Global Corporation (TSXV: ABCN) (OTC: ABCCF) (“ABcann” or the “Company”) is pleased to announce that it has amended and extended the research...
Earlier this month, Tilray made a big change in how it will be marketing its medical cannabis products. Historically, it was selling its dried cannabis products under common strain names,...
Horizons Medical Marijuana Life Sciences ETF (TSX: HMMJ) (OTC: HMLSF) added three names to its portfolio today as it scaled back several positions. The ETF had shared its top holdings...
ABcann Global and Cannabis Wheaton Sign Interim Agreement for Construction of Additional Cannabis Cultivation Facility VANCOUVER, BC–(Marketwired – May 29, 2017) – ABcann Global Corporation (TSXV: ABCN) (OTC: ABCCF)...
ABcann Extends Agreement With Medical Cannabis Pioneer OTTAWA, May 09, 2017 (GLOBE NEWSWIRE) — ABcann Global Corporation (TSX-V:ABCN) (the “Company”) is pleased to announce that Raphael Mechoulam has agreed...
ABcann Global Announces Appointment of W. Brett Wilson to Advisory Board NAPANEE, Ontario, May 04, 2017 (GLOBE NEWSWIRE) — ABcann Global Corporation (TSXV:ABCN) (the “Company”) is pleased to announce...
ABcann Global Announces Closing of Qualifying Transaction and Concurrent Financings NAPANEE, Ontario, May 03, 2017 (GLOBE NEWSWIRE) — ABCANN GLOBAL CORPORATION (TSXV: ABCN) (formerly Panda Capital Inc.) (“ABcann” or...
While Health Canada, which provided an update on April 24th, continues to get the official data out to the public very slowly, the patient enrollment growth in the ACMPR...
Panda and ABcann Medicinals Announce Multi-Stage Product Testing Methodology OTTAWA, April 24, 2017 (GLOBE NEWSWIRE) — Panda Capital Inc. (NEX:PDA.H) (the “Company”) is pleased to announce details of the...
In advance of ABcann Global (TSXV: ABCN) trading publicly in the very near future, we hosted CEO Aaron Keay to discuss the company. Keay began by reviewing the corporate...
Panda And ABcann Medicinals Announce Increase In Concurrent Subscription Receipt Financing And Also Announce Results of Annual General Meeting OTTAWA, April 12, 2017 (GLOBE NEWSWIRE) — Panda Capital Inc....
With Canada set to make history this week by tabling legislation to make the nation the first G-7 country to legalize cannabis for adult use, many investors are focusing...
Panda and ABcann Medicinals Provide Update on Qualifying Transaction and Announce $8 Million Brokered Financing OTTAWA, ON / ACCESSWIRE / March 23, 2017 / Panda Capital Inc. (TSX-V: PDA.H)...
After a boom in the stock prices of Canadian licensed producers (LPs) in 2016 that left the average stock up more than 355%, the sector is performing very well...
OTTAWA, ON / ACCESSWIRE / December 2, 2016 / Panda Capital Inc. (TSX-V: PDA.H) (“Panda”) is pleased to announce that it has entered into a definitive amalgamation agreement dated...
PharmaCan Announces Corporate Rebranding to Become Cronos Group TORONTO, ON–(Marketwired – October 06, 2016) – PharmaCan Capital (TSXV: MJN) (“the Company”) today announced a corporate rebranding to Cronos Group....
Vice’s Motherboard explored how Canadian botanists are focusing on cannabis, featuring Professor Mike Dixon, who is working with Canadian LP ABcann to produce consistent cannabis using technology. The company’s...
Co-founder, President and CEO Paul Rosen has resigned from PharmaCan Capital (TSXV:MJN). Rosen, a pioneer in the Canadian cannabis industry, created a merchant bank to invest in the industry...
There is little doubt that the highly regulated Canadian medical cannabis market is spawning interest in other geographies that are building medical cannabis programs. The most recent example is...
